Clinigen Group (CLIN)

Sector:

Food Pharmacy Retail

Index:

FTSE AIM 50

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

932.50p
   
  • Change Today:
    -25.50p
  • 52 Week High: 1,043.00
  • 52 Week Low: 721.00
  • Currency: UK Pounds
  • Shares Issued: 132.19m
  • Volume: 164,765
  • Market Cap: 1,232.69m
  • Beta: 0.01

Clinigen Group Overview

Clinigen Group is in the food pharmacy retail sector and is currently trading at 932.50p per share. In the last year Clinigen Group's share price has ranged from 721.00p to 1,043.00p and brokers are currently rating this stock as 'strong buy'.

1 Day Chart (18-04-2019)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.6% 0.7%
Div Cover 8.1 8.4
Op Mrgn 10.9% 19.6%
ROCE 75.9%  
Latest F'cast
P/E 20.5 17.5
PEG 2.1 1.0
Pr/Revenue 3.2 2.7
Pr/Book 3.5  
Latest F'cast
Revenue 26.1% 19.1%
PBT 154.6% 148.5%
EPS 9.9% 17.6%
DPS 12.0% 13.1%

Clinigen Group Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-14 126.64 21.24 24.50p 15.4 1.5 +10% 3.10p 0.8%
30-Jun-15 184.40 8.30 28.00p 22.3 1.6 +14% 3.40p 0.5%
30-Jun-16 339.90 15.90 33.40p 18.1 1.0 +19% 4.00p 0.7%
30-Jun-17 302.30 14.10 41.30p 20.8 0.9 +24% 5.00p 0.6%
30-Jun-18 381.20 35.90 45.40p 20.2 2.0 +10% 5.60p 0.6%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Clinigen Group Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-19 454.02 89.19 53.40p 17.5 1.0 +18% 6.33p 0.7%
30-Jun-20 537.03 129.95 76.42p 12.2 0.3 +43% 8.14p 0.9%

Copyright © 2019 FactSet Research Systems Inc. All rights reserved.

Clinigen Group Company Announcements

Clinigen completes US Proleukin rights acquisition 02-Apr-2019 07:00 RNS
Grant of share options and PDMR notification 29-Mar-2019 14:40 RNS
Half Year Results 27-Feb-2019 07:00 RNS

Latest Clinigen Group Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Clinigen Group Market Data

Currency UK Pounds
Share Price 932.50p
Change Today -25.50p
% Change -2.66 %
52 Week High 1,043.00
52 Week Low 721.00
Volume 164,765
Shares Issued 132.19m
Market Cap 1,232.69m
Beta 0.01

Clinigen Group Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
87.25% below the market average87.25% below the market average87.25% below the market average87.25% below the market average87.25% below the market average
53.85% below the sector average53.85% below the sector average53.85% below the sector average53.85% below the sector average53.85% below the sector average
Price Trend
62.23% above the market average62.23% above the market average62.23% above the market average62.23% above the market average62.23% above the market average
23.08% above the sector average23.08% above the sector average23.08% above the sector average23.08% above the sector average23.08% above the sector average
Income
88.66% below the market average88.66% below the market average88.66% below the market average88.66% below the market average88.66% below the market average
66.67% below the sector average66.67% below the sector average66.67% below the sector average66.67% below the sector average66.67% below the sector average
Growth
80.28% above the market average80.28% above the market average80.28% above the market average80.28% above the market average80.28% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

What The Brokers Say

Strong Buy 5
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 5
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Clinigen Group Dividends

  Latest Previous
  Interim Final
Ex-Div 21-Mar-19 08-Nov-18
Paid 12-Apr-19 30-Nov-18
Amount 1.95p 3.84p

Trades for 18-Apr-2019

Time Volume / Share Price
16:39 6,200 @ 940.37p
16:39 6,200 @ 940.37p
16:39 6,200 @ 937.59p
16:39 6,200 @ 937.59p
16:35 51,763 @ 932.50p

Clinigen Group Key Personnel

CEO Shaun Edward Chilton

Top of Page